 |
Please Join Us for a Special Symposium
Breast Tomosynthesis: How a More Accurate Mammogram Can Benefit Patients and Healthcare Facilities
Please join us for this special symposium on 3D Mammography (breast tomosynthesis) to learn more about how the technology works and the important impact it’s having on breast cancer detection.
The presentation will include a results overview from current peer-reviewed publications including details on how 3D mammography has been shown to significantly increase the detection of invasive breast cancers while also reducing false-positive recalls.1-3
Donna Singer, the CEO of Utah Navajo Health Systems, will also discuss the reasoning behind bringing this technology to an underserved and historically non-compliant patient population; the implementation effort following that decision; and the positive impact 3D mammography has had on clinical care and healthcare costs for the facility.
Speakers
Donna Singer
Chief Executive Officer
Utah Navajo Health System, Inc. |
Andrew Smith, Ph.D.
Vice President, Image Science
Hologic, Inc. |
| |
|
|
We have the technology.
You have the power.
Let's unite and do something good for women.
Visit Hologic at AHRA to learn more about Selenia Dimensions tomosynthesis low dose 3D mammography options including C-View software and the Affirm tomosynthesis biopsy procedure.
Don't miss the chance to see our new Horizon DXA system and our interventional solutions including the MultiCare Platinum breast biopsy table and Eviva breast biopsy device.
You’ll also have the opportunity to see all of the ways Hologic supports your business — from reimbursement guidance and service programs to education and marketing tools — we’ve got you covered.
Together we can help improve outcomes for women. Learn more at the Hologic exhibit, #110 or by contacting us.
|
|
|
Breast Tomosynthesis | Digital Mammography | Breast MRI | Breast Ultrasound
Breast Biopsy | Bone Densitometry | Targeted Radiation Therapy |
1. Skaane P, Bandos A, Gullien R, et al. “Comparison of Digital Mammography Alone and Digital Mammography Plus Tomosynthesis in a Population-based Screening Program.” Radiology. 2013 Apr; 267(1):47-56. Epub 2013 Jan 7.
2. Ciatto S, Houssami N, Bernardi D, et al. “Integration of 3D Digital Mammography with Tomosynthesis for Population Breast-Cancer Screening (STORM): A Prospective Comparison Study” The Lancet Oncology. Epub 2013 Apr 25.
3. Rose S, Tidwell A, Bujnock L, et al. “Implementation of Breast Tomosynthesis in a Routine Screening Practice: An Observational Study.” American Journal of Roentengenology. 2013 Jun; 200(6): 1401-1408. Epub 2013 May 22.
Hologic, Affirm, C-View, Dimensions, Eviva, Horizon, MultiCare and Selenia are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the U.S. and/or other countries. This information is intended for medical professionals in the U.S. and other markets, and is not intended as a product solicitation or promotion where such activities are prohibited. Because Hologic materials are distributed through websites, eBroadcasts and tradeshows, it is not always possible to control where such materials appear. For specific information on what products are available for sale in a particular country, write to womenshealth@hologic.com. |
EMB-00498 |
|
|
|